Trusted by

Predice la respuesta del paciente y diseña terapias celulares.

Descodifica el sistema inmunitario para la ingeniería de terapias.

Presentamos el  Modelo Fundacional con osPharma.

El sistema inmunitario es una red dinámica y rica en datos, moldeada por las enfermedades, los tratamientos y el tiempo. Omniscope aporta claridad a esta complejidad a través de nuestro modelo fundacional del sistema inmunitario.

El modelo fundacional de Omniscope revela los principios fundamentales de la respuesta inmunitaria y el diseño óptimo de terapias celulares, acelerando el descubrimiento de fármacos y el diagnóstico de patologías en áreas como el cáncer y las enfermedades autoinmunes, infecciosas y neuroinmunitarias.

Proporcionamos información clave para:
Predicción de la respuesta al tratamiento
Estratificación de pacientes
Seguimiento de la dinámica inmunitaria
Diseño de terapias in silico

Ya sea en el desarrollo de fármacos o en la estrategia clínica, Omniscope impulsa una nueva era de inmunología de precisión, situando al sistema inmunitario en el centro del éxito terapéutico.

Omniscope Logo Solid SVG

Decodificar el sistema inmunitario.

Leer.

Inmunosecuenciación a escala.

High through-put TCR and BCR sequencing of T and B cells
Contactar

TCR SEQUENCING (osT)
Provides full VDJ sequences and paired alpha/beta receptor chains of highly expanded clones to quantify and characterize T cell dynamics.

osT

Perfilado de receptores de células T con resolución de célula única para el desarrollo terapéutico.

BCR SEQUENCING (osB)
Provides full VDJ sequences, hypermutation profiles and heavy/light chain pairing to quantify and characterize B cell dynamics.

osB

Perfilado de receptores de células B con resolución de célula única para el desarrollo terapéutico.

TCR SEQUENCING (osTCR)
Ideal for cost-efficient biomarker discovery and tracking, in large cohort studies.

osTCR

Resolución de molécula única para un perfilado preciso y cuantitativo de los receptores de células T.

BCR SEQUENCING (osBCR)
Ideal for diagnostics and measuring efficacy/safety of novel therapeutics.

osBCR

Resolución de molécula única para el perfilado cuantitativo de los receptores de células B.

Analizar.

El portal hacia el conocimiento inmunitario.

High through-put TCR and BCR sequencing of T and B cells
Solicitar demo

IMMUNE PORTAL (osIP)
Generate reports and leverage in-house AI enabled analysis for:
•  Public database matching
Track longitudinal dynamics across individuals and cohorts
•  Similarity networks (osNetworks)
•  Publication-ready visualizations

osIP

El portal inmunitario de Omniscope proporciona modelos computacionales integrales para interrogar el sistema inmunitario a nivel celular.

IMMUNE DATABANK (osID)
Access and query individual and cohort immune profiles spanning major diseases and populations
•  HLA, sex, disease, and therapy-matched cohorts for robust comparative analysis.
•  Precision research value with clinical annotation and metadata.

osID

El banco de datos inmunitarios de Omniscope, construido a partir de diversas poblaciones, indicaciones y resultados clínicos.

Escribir.

Identificación de candidatos para terapia celular.

High through-put TCR and BCR sequencing of T and B cells
Saber más

ImmuneGPT
A generative pipeline trained on Omniscope Immune Databank (osID: world's the largest immune receptor database) designed to create novel TCR-T candidates and accelerate  therapeutic development.

ImmuneGPT

Pipeline generativo de extremo a extremo para el diseño de vacunas y TCR-T

Lanzamiento de nuevo producto próximamente. Mantente informado.

Real science, true insights

Immune repertoire profiling to monitor response to therapies.

Experience the power of single-molecule resolution for deep, quantitative, and cost-efficient profiling of T and B cell repertoires.

Track clonotypes to identify and monitor immunotherapy response.

Repertoire dynamics

Characterize immunological response to therapy including clonal dynamics. Analyze longitudinal samples or variations between patients for comparison and contrast.

Database matching

Track T or B cell clonotypes from diverse samples, pre and post-treatment, longitudinally.

Quantify strength of response

Identify clonotypes indicative of response. Query response-signatures and explore their dynamics inter-patients.

Immune repertoire profiling to identify and predict responders to immunotherapies.

Leverage single-molecule resolution for deep, quantitative, and cost-efficient profiling of T and B cell repertoires.

Determine which patients are likely to benefit from your drug.

Repertoire dynamics

Discover broader spectrum of expansion clonal dynamics across therapeutic regimen.

Clonotypes tracking

Identify and track clonotypes indicative of response to immunotherapy, pre and post-treatment, and longitudinally.

Quantify strength of response

Measure expansion profile dynamics of clonotypes of responding and non-responding patients to quantify and investigate response strength.

Immune repertoire profiling to predict adverse reaction.

Leverage single-molecule resolution for deep, quantitative, and cost-efficient profiling of T and B cell repertoires.

Discover patient populations that are at risk of adverse reactions with your drug.

Repertoire dynamics

Explore deep range of expanded clones and their dynamics. Analyze longitudinal samples or variations between patients for comparison and contrast.

Database matching

Compare clonotypes found in your samples to public databases and Omniscope’s comprehensive disease library.

Identify clones

Identify clonotypes indicative of disease signature for diagnostic purposes.

Immune repertoire profiling for your therapeutic breakthrough.

Experience the power of single-cellular resolution for deep, quantitative, and qualitative profiling of T and B cell repertoires.

Accelerate your therapy development by identifying and testing (in silico & in vitro) novel candidates for advanced cell therapy.

Uncover novel targets

Leverage the power of single-cellular resolution to identify receptor candidates for advanced cell therapy and accelerate your therapeutic development.

Alpha/Beta and Heavy/Light chain pairing

Obtain full-length VDJ & Alpha / Beta, heavy/light chain pairing to enable novel therapeutic candidates.

In silico drug design

Leverage our GenAI capabilities to develop your therapeutic pipeline. Explore our immune databank to design your therapy.

Applications

View all

See what your immune system is seeing.

Latest publications.

View all

Get access now.

Decode the immune system to...

...identify disease associated signatures.
...predict therapy response.
...guide therapeutic discovery.
...support cellular engineering.

Omniscope Immune Portal preview